US Food and Drug Administration (US FDA) for its ANDA Norepinephrine Bitartrate Injection USP, 4 mg/4 mL (1 mg/mL) ...

Biocon Ltd share price was up by 1.50% from the previous closing price of ₹336.35. Who are peers of Biocon Ltd? The peers of Biocon Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Norepinephrine bitartrate injection is a critical medication used to raise blood pressure in adult patients suffering from ...

Biocon share price: Pharmaceutical company Biocon shares were in demand on Wednesday, March 5, 2025, as the scrip rose up to 3.08 per cent to hit an intraday high of Rs 324.50 per share. The rise in ...

Biocon share price: Shares of Biocon Ltd rose 3% after Biocon Pharma received FDA approvals for cancer drugs Lenalidomide and Dasatinib, enhancing its US oncology market presence. The company also got ...

Agencies Biocon Share Price: This collaboration is in addition to Biocon Biologics' own insulin aspart drug product for the United States, which is currently under review by the U.S. Food and Drug ...

Natural Biocon (India) Ltd share price was down by -1.96% from the previous closing price of ₹12.76. Who are peers of Natural Biocon (India) Ltd? The peers of Natural Biocon (India) Ltd are ...

The approval covers the norepinephrine bitartrate injection 4 mg/4 mL (1 mg/mL) single-dose vial, which can now be ...

What is the Natural Biocon India Ltd share price today? The Natural Biocon India Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹12.87 today. What is the Market Cap of Natural Biocon India Ltd?

is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period. Earnings Per Share (TTM ...

Biotechnology firm Biocon Ltd on Thursday (March 6) said its arm Biocon Biologics Ltd has entered into a strategic collaboration with Civica Inc, a not-for-profit pharmaceutical company, to enhance ...